IVD instrument
Luminex Receives CE Mark for New Newborn-Screening Platform
Luminex Corp. announced today that it has received CE marking of both the xMAP NeoPlex4 Assay and NeoPlex System. This system represents a change in the way newborn screening is performed, providing four assays from one blood spot punch, reducing sample requirements and improving laboratory efficiency, the company says.  The NeoPlex4 Assay simultaneously tests four analytes, T4, TSH, 17OHP, and total IRT, which can be indicators of congenital hypothyroidism, congenital adrenal hyperplasia...